Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00108_DB00291_nanopub.RANs6-SwisbQwW0ZEoA8XI8j6GLvaOPboiyxL0zq_3zR8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00108_DB00291 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB00291 label "DDI between Natalizumab and Chlorambucil - Immunosuppressants such as chlorambucil may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants. [drugbank_resource:DB00108_DB00291]" assertion.
- drugbank_resource:DB00108_DB00291 identifier "drugbank_resource:DB00108_DB00291" assertion.
- drugbank_resource:DB00108_DB00291 title "DDI between Natalizumab and Chlorambucil - Immunosuppressants such as chlorambucil may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants." assertion.
- drugbank:DB00291 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00291 assertion.
- drugbank:DB00108 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00291 assertion.